Evidence map›Paper›PMID 36902478›Full record

ReviewInternational journal of molecular sciences2023

The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis.

Lin Fu, Xiaotong Zhou, Qian Jiao, Xi Chen

Open access · goldFull text readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. TRIM56 Promotes White Adipose Tissue Browning to Attenuate Obesity by Degrading TLE3.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Review
  10. Multifaceted role ofMedComm · 2024
    Review
  11. Article
  12. Article
  13. TRIM44 Promotes Rabies Virus Replication by Autophagy-Dependent Mechanism.International journal of molecular sciences · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Expression ofFuture virology · 2023
    Article
  18. Review
  19. CD8Frontiers in cellular neuroscience · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lin FuSchool of Basic Medicine, Qingdao University, Qingdao 266000, China.
Xiaotong ZhouSchool of Basic Medicine, Qingdao University, Qingdao 266000, China.
Qian JiaoSchool of Basic Medicine, Qingdao University, Qingdao 266000, China.
Xi ChenSchool of Basic Medicine, Qingdao University, Qingdao 266000, China.
Qingdao University · CN

Funding

National Natural Science Foundation of China 82273034the Natural Science Foundation of Shandong Province ZR2022MC035the Shandong Youth Science and Technology Innovation Team 2022KJ298
6 · The paper itself

Abstract

As a member of the TRIM (tripartite motif) protein family, TRIM56 can function as an E3 ubiquitin ligase. In addition, TRIM56 has been shown to possess deubiquitinase activity and the ability to bind RNA. This adds to the complexity of the regulatory mechanism of TRIM56. TRIM56 was initially found to be able to regulate the innate immune response. In recent years, its role in direct antiviral and tumor development has also attracted the interest of researchers, but there is no systematic review on TRIM56. Here, we first summarize the structural features and expression of TRIM56. Then, we review the functions of TRIM56 in TLR and cGAS-STING pathways of innate immune response, the mechanisms and structural specificity of TRIM56 against different types of viruses, and the dual roles of TRIM56 in tumorigenesis. Finally, we discuss the future research directions regarding TRIM56.

Indexed as

CarcinogenesisTripartite Motif ProteinsVirusesHumansUbiquitin-Protein LigasesTRIM56 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligasesantivirusinnate immune responseTRIM56tumor

Identifiers

PMID36902478
PMCPMC10003129
OpenAlexW4323363136

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.